Reports for ABBVIE CORPORATION
Company Name
ABBVIE CORPORATION
Totals |
||
Shortage reports |
121 |
|
| Actual shortage: | 6 (5%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 5 (4%) | |
| Resolved: | 110 (91%) | |
Discontinuation Reports |
11 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 8 (73%) | |
| Reversed: | 3 (27%) | |
Late reports |
5 (4%) |
|
Overdue reports |
4 (67%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| BYSTOLIC | 10MG | TABLET | Resolved | 2023-03-22 | 2023-08-04 | 187625 |
| BYSTOLIC | 20.0MG | TABLET | Resolved | 2019-05-25 | 2019-06-07 | 84755 |
| BYSTOLIC | 20MG | TABLET | Resolved | 2022-01-20 | 2022-09-01 | 153204 |
| CONSTELLA | 145MCG | CAPSULE | Resolved | 2019-05-25 | 2019-06-11 | 84767 |
| CONSTELLA | 290MCG | CAPSULE | Resolved | 2018-11-20 | 2019-01-09 | 67153 |
| CONSTELLA | 290MCG | CAPSULE | Resolved | 2019-02-19 | 2019-02-27 | 76263 |
| CONSTELLA | 290MCG | CAPSULE | Resolved | 2019-05-25 | 2019-06-07 | 84770 |
| CONSTELLA | 290MCG | CAPSULE | Resolved | 2022-06-09 | 2022-07-10 | 162248 |
| CONSTELLA | 290MCG | CAPSULE | Resolved | 2023-09-08 | 2023-09-22 | 203963 |
| CONSTELLA | 72MCG | CAPSULE | Resolved | 2019-05-25 | 2019-06-07 | 84773 |
| CONSTELLA | 72MCG | CAPSULE | Resolved | 2022-06-09 | 2022-07-10 | 162251 |
| FETZIMA | 20MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-05-25 | 2019-06-07 | 84776 |
| FETZIMA | 80MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-05-25 | 2019-06-07 | 84779 |
| FETZIMA | 120MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2023-07-21 | 2023-08-16 | 199542 |
| FML | 0.1% | SUSPENSION DROPS | Resolved | 2022-11-29 | 2023-09-29 | 176192 |
| FML | 0.1% | DROPS | Resolved | 2019-08-14 | 2019-09-21 | 91579 |
| FML | 0.1% | DROPS | Resolved | 2019-10-24 | 2019-11-08 | 97085 |
| FML | 0.1% | DROPS | Resolved | 2020-02-10 | 2020-03-05 | 105623 |
| FML | 0.1% | DROPS | Resolved | 2020-03-25 | 2020-04-22 | 109342 |
| KALETRA | 100MG 400MG | SOLUTION | Resolved | 2022-05-03 | 2022-05-26 | 159917 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ALPHAGAN | 0.2% | LIQUID | Reversed | 2021-12-09 | 2023-12-14 | 150885 |
| HOLKIRA PAK | 50MG 12.5MG 250MG 75MG | KIT TABLET | Discontinued | 2017-11-30 | 2018-08-30 | 31302 |
| HUMIRA | 40MG | SOLUTION | Discontinued | 2020-06-29 | 2020-11-19 | 119141 |
| LUPRON | 5MG | SOLUTION | Discontinued | 2022-01-31 | 2022-08-17 | 153896 |
| MODERIBA | 200MG | TABLET | Discontinued | 2017-11-21 | 2018-08-30 | 29907 |
| MODERIBA | 400MG | TABLET | Discontinued | 2017-11-30 | 2018-08-30 | 31316 |
| MODERIBA | 600MG | TABLET | Discontinued | 2017-11-20 | 2018-05-07 | 29835 |
| NORVIR | 80MG | SOLUTION | Discontinued | 2019-02-20 | 2019-04-01 | 76354 |
| TECHNIVIE | 12.5MG 75MG 50MG | TABLET | Discontinued | 2017-11-20 | 2018-05-07 | 29839 |
| VIBERZI | 75MG | TABLET | Reversed | 2022-03-23 | 2022-06-29 | 157156 |
| VIBERZI | 100MG | TABLET | Reversed | 2022-03-23 | 2022-06-22 | 157159 |
Showing 1 to 11 of 11